drugset
drugset / Trial / NCT05366595

Zinc Supplementation in Pediatric Sepsis

NCT05366595 ↗

Phase 2 Completed 72 enrolled Mansoura University
RandomizedParallel-groupSingle-blindTreatment

Summary

a single blinded randomized controlled clinical trial that was conducted to evaluate the role of zinc supplementation in improving the outcome of infants and children with sepsis in pediatric intensive care unit.

Timeline

Start
2019-07-31
Primary completion
2022-06-10
Completion
2022-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zinc Sulfate Unknown 10 mg Oral
Comparator Zinc Sulfate Unknown 20 mg Oral

Indications

No indication recorded.